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Abstract
Background: ALS2/alsin is a guanine nucleotide exchange factor for the small GTPase Rab5 and involved in
macropinocytosis-associated endosome fusion and trafficking, and neurite outgrowth. ALS2 deficiency accounts for a
number of juvenile recessive motor neuron diseases (MNDs). Recently, it has been shown that ALS2 plays a role in
neuroprotection against MND-associated pathological insults, such as toxicity induced by mutant Cu/Zn superoxide
dismutase (SOD1). However, molecular mechanisms underlying the relationship between ALS2-associated cellular function
and its neuroprotective role remain unclear.
Methodology/Principal Findings: To address this issue, we investigated the molecular and pathological basis for the
phenotypic modification of mutant SOD1-expressing mice by ALS2 loss. Genetic ablation of Als2 in SOD1
H46R, but not
SOD1
G93A, transgenic mice aggravated the mutant SOD1-associated disease symptoms such as body weight loss and motor
dysfunction, leading to the earlier death. Light and electron microscopic examinations revealed the presence of
degenerating and/or swollen spinal axons accumulating granular aggregates and autophagosome-like vesicles in early- and
even pre-symptomatic SOD1
H46R mice. Further, enhanced accumulation of insoluble high molecular weight SOD1, poly-
ubiquitinated proteins, and macroautophagy-associated proteins such as polyubiquitin-binding protein p62/SQSTM1 and a
lipidated form of light chain 3 (LC3-II), emerged in ALS2-deficient SOD1
H46R mice. Intriguingly, ALS2 was colocalized with LC3
and p62, and partly with SOD1 on autophagosome/endosome hybrid compartments, and loss of ALS2 significantly lowered
the lysosome-dependent clearance of LC3 and p62 in cultured cells.
Conclusions/Significance: Based on these observations, although molecular basis for the distinctive susceptibilities to ALS2
loss in different mutant SOD1-expressing ALS models is still elusive, disturbance of the endolysosomal system by ALS2 loss
may exacerbate the SOD1
H46R-mediated neurotoxicity by accelerating the accumulation of immature vesicles and misfolded
proteins in the spinal cord. We propose that ALS2 is implicated in endolysosomal trafficking through the fusion between
endosomes and autophagosomes, thereby regulating endolysosomal protein degradation in vivo.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a heterogeneous group of
progressive neurodegenerative disorders characterized by a
selective loss of upper motor neurons (UMN) in the cerebral
cortex and lower motor neurons (LMN) in the brainstem and
spinal cord [1]. While most of the cases reported are sporadic, 5–
10% are familial. Thus far, more than 10 ALS-associated loci have
been assigned, and several causative genes, including SOD1
(ALS1), ALS2, SETX (ALS4), SPATACSIN/SPG11 (ALS5), FUS
(ALS6), VAPB (ALS8), ANG (ALS9), and TARDBP (ALS10) have
been identified and characterized [1,2,3].
ALS2 is a causative gene for a juvenile autosomal recessive form
of motor neuron diseases (MNDs) [4,5,6], including amyotrophic
lateral sclerosis 2 (ALS2) [7] (OMIM 205100), juvenile primary
lateral sclerosis (PLSJ) [8] (OMIM 606353), and infantile-onset
ascending hereditary spastic paralysis (IAHSP) [9] (OMIM
607225). These disorders are characterized by ascending
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of 19 independent ALS2 mutations from 17 families have been
reported [4,5,6,10,11,12,13,14]. They are predicted to result in
either premature termination of translation or substitution of an
evolutionarily conserved amino acid for the ALS2-coded protein,
ALS2 or alsin, leading to loss of its function. ALS2 is a guanine
nucleotide exchange factor for the small GTPase Rab5 [15] and
involves in macropinocytosis-associated endosome trafficking and
fusion [16,17], and neurite outgrowth [17,18,19]. Loss of these
functions accounts for motor dysfunction and axonal degeneration
in the ALS2-linked MNDs. Logically designed mouse studies could
provide persuasive evidence that loss of ALS2 triggers motor
neuron degeneration. However, mice lacking ALS2 cannot
recapitulate the complex disease phenotypes, despite the subclin-
ical levels of motor dysfunction and axonal degeneration in aged
animals [6,20,21]. Thus, although there are potentially important
clinical implications of these observations, the physiological
functions of ALS2 and the molecular mechanisms underlying
the motor dysfunction resulting from ALS2 deficiency remain to
be clarified.
Most efforts to delineate ALS/MND pathogenesis have
converged on the mutations in SOD1, encoding Cu/Zn superoxide
dismutase (SOD1), which accounts for most prevalent form of the
autosomal dominant familial ALS [22]. More than 120 different
SOD1 mutations have been identified (http://alsod.iop.kcl.ac.uk/
als), and several transgenic mouse lines expressing disease
causative SOD1 mutants have been generated and thoroughly
characterized [23]. Nonetheless, no consensus has yet emerged as
to how SOD1 mutations lead to selective death of motor neurons,
except that multiple toxicity pathways including oxidative stress,
endoplasmic reticulum (ER) stress, excitotoxicity, mitochondrial
dysfunction, neural inflammation, protein misfolding and accu-
mulation, and dysfunctional intracellular trafficking, are implicat-
ed in the pathogenesis of ALS/MNDs [1,24].
Recently, it has been reported that overexpression of ALS2
protects cultured motor neuronal cells from toxicity induced by
mutant SOD1 [25]. Further, loss of ALS2 renders neurons more
susceptible to excitotoxicity [26], while cell death induced by
neurotoxic stimuli, such as N-methyl-D-aspartate, is significantly
suppressed by overexpression of ALS2 [27]. Moreover, Als2-null
mice are slightly vulnerable to oxidative stress [28]. These
observations imply a neuroprotective function of ALS2 against
ALS/MND-associated pathological insults. On the other hand, in
vivo studies have demonstrated that loss of ALS2 does not affect the
motor neuron degeneration and survival of SOD1
G93A mice
[29,30], which does not support the functional interaction between
ALS2 and mutant SOD1-mediated toxicity in vivo. However, with
the use of only a single mutant SOD1 transgenic line, such notions
still remain inconclusive. Rather, it is possible that the extremely
rapid progression of motor dysfunction observed in high-copy
number SOD1
G93A mice could overwhelm the modest symptoms
by the ALS2 deficiency [29].
To clarify these issues, we used SOD1
H46R mice, which exhibit a
widespread axonal degeneration with slowly progressive motor
neuron degeneration in the spinal cord [31] instead of SOD1
G93A
mice, and generated SOD1
H46R mice on an Als2-null background.
SOD1
H46R mutation accounts for a mild form of familial ALS that
was originally identified in Japanese kindred [32]. We here
revealed that loss of ALS2 exacerbated the SOD1
H46R-associated
disease symptoms in mice, and identified ALS2 as a novel
regulator for the endolysosomal system. Our findings suggest that
ALS2 plays a role in the maturation of autophagosomes through
the endosome-autophagosome fusion, thereby regulating endoly-
sosomal trafficking in vivo.
Results
Loss of ALS2 results in a shorter lifespan in SOD1
H46R mice
To investigate the effect of ALS2 expression on the pathogenesis
for mutant SOD1-mediated MNDs, we generated congenic lines
(C57BL/6N) with 6 different genotypes; Als2
+/+ (wild-type),
Als2
+/2, Als2
2/2, Als2
+/+;SOD1
H46R, Als2
+/2;SOD1
H46R, and
Als2
2/2;SOD1
H46R. The mutant alleles were transmitted in the
expected Mendelian ratio (Table S1). A copy number of the
SOD1
H46R transgene (,20 copies) [31], which affected the disease
severity [33], remained unchanged in the course of these mating
schemes (Figure S1).
During the experimental periods, both wild-type and Als2
2/2
mice showed a constant increase in their body weight (Figure S2A
and S2B), while mice carrying the SOD1
H46R transgene reached
their maximum body weight at 12–14 weeks of age, and terminally
decreased as disease symptoms progressed (Figure 1A and 1B).
Notably, loss of ALS2 in SOD1
H46R mice (Als2
2/2;SOD1
H46R)
showed a marked and earlier decrease in their body weight
compared to either Als2
+/+;SOD1
H46R or Als2
+/2;SOD1
H46R
littermates (Figure 1A and 1B). Further, Kaplan-Meier survival
analysis revealed that Als2
2/2;SOD1
H46R mice died earlier than
either Als2
+/+;SOD1
H46R or Als2
+/2;SOD1
H46R littermates
(Figure 1C). Importantly, these exacerbated phenotypes by
ALS2 loss were restorable by crossing to transgenic mice
expressing human ALS2 (ALS2-tg; line L34-1) (Als2
2/2;
SOD1
H46R;ALS2 mice), albeit ALS2 overexpression per se did not
show any obvious beneficial effects on lifespan in SOD1
H46R mice
(Figure 1D and S3). The results indicate that loss of ALS2
aggravates disease symptoms associated with SOD1
H46R expres-
sion in mice. By contrast, loss of ALS2 in SOD1
G93A mice did not
affect their lifespan (Figure S2C) as previously reported [29,30],
suggesting a limited role of ALS2 in SOD1
G93A-mediated
pathogenesis in vivo.
Loss of ALS2 aggravates motor dysfunction in SOD1
H46R
mice
As mice expressing SOD1
H46R exhibited progressive motor
dysfunction and paralysis, particularly of the hind limbs, we next
assessed whether loss of ALS2 in SOD1
H46R mice affects the course
of motor deficits by conducting quantitative behavioral analyses.
First, to evaluate motor coordination and balance, we performed
balance beam test, by which the onset of disease could be
sensitively determined [34]. Als2
2/2;SOD1
H46R mice showed an
earlier motor dysfunction, in which the onset of disease (,15
weeks of age) was approximately 3 weeks earlier than those (,18
weeks of age) of Als2
+/+;SOD1
H46R or Als2
+/2;SOD1
H46R litter-
mates (Figure 2A). Further, analyses of rearing and cage activities
revealed that although there were no significant differences in their
activities among all pre-symptomatic mice (12 weeks of age) with
different genotypes, Als2
2/2;SOD1
H46R mice showed a significant-
ly lower spontaneous motor activity than wild-type or
Als2
+/2;SOD1
H46R littermates at a later stage of the disease (18
week of age) (Figure 2B and 2C).
SOD1
H46R mice show an axonal degeneration in the
spinal tracts from an early symptomatic stage
To determine whether these motor phenotypes are associated
with motor neuron degeneration, we conducted histological
analyses using early symptomatic mice (16–18 weeks of age).
Although there were no evidences for the motor neuron loss at this
stage, a wide-spread axonal degeneration in the spinal tracts of the
lateral and ventral columns was evident, particularly in
Als2
2/2;SOD1
H46R mice (Figure 3A).
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and autophagosome-like structures are accumulated in
the spinal cord of SOD1
H46R mice
To investigate the histopathology in more detail, we next
conducted an electron microscopic (EM) analysis. Although there
werenoobservableabnormalitiesinsomaofmotorneurons(datanot
shown), we observed the degenerative and swollen axons with the
accumulation ofgranularaggregates,disorganizedfibrillarmaterials,
multivesicularbodies(MVBs),and/orautophagosome-likevesiclesin
the spinal cord of Als2
2/2;SOD1
H46R and Als2
+/+;SOD1
H46R mice at
an early symptomatic stage (Figure 3B and 3C). Further, membrane
sacculescontaininggranular/osmiophilicaggregates(Figure3D)and
autophagosome-like vesicles (Figure 3E) were observed. Astrocytes
containing osmiophillic aggregates were also occasionally observed
(Figure 3F). Notably, in Als2
2/2;SOD1
H46R mice, these pathologic
phenotypes were evident even at 8 weeks of pre-symptomatic stage
(Figure 3G), but not in a same stage of Als2
+/+;SOD1
H46R mice (data
not shown). These data underscore the relevance of axonal
dysfunction and/or degeneration, probably caused by the dysfunc-
tional axonal trafficking, on the disease onset in SOD1
H46R-
expressing mice.
Loss of ALS2 promotes the progressive accumulation of
insoluble proteins in the spinal cord of SOD1
H46R mice
First, we confirmed that there were no significant differences in
the expression levels of the SOD1
H46R transcript (Figure S4A) and
soluble SOD1
H46R protein (Figure 4, S5A, and S6A) among three
different groups of mice carrying the human SOD1 transgene; i.e.,
Als2
+/+;SOD1
H46R, Als2
+/2;SOD1
H46R, and Als2
2/2;SOD1
H46R.
These results indicate that the exacerbation of motor dysfunction
seen in SOD1
H46R mice lacking ALS2 was not simply due to the
increased level of the SOD1
H46R expression.
To identify the molecular factors that were associated with
behavioraland pathologicalfeaturesobservedinAls2
2/2;SOD1
H46R
mice, we conducted western blot analysis of the lumbo-sacral cord
extracts using a panel of antibodies, and performed their
quantitative analyses. Although the levels of the ALS-related
neuronal intermediate filament proteins [peripherin and neurofil-
ament heavy chain (NFH)] [35] and the ALS-causative gene
product [TAR DNA-binding protein 43-kD (TDP-43)] [1,2] were
unchanged, a progressive accumulation of insoluble high-molecular
weight (HMW) SOD1 and poly-ubiquitinated proteins was
observed in mice expressing SOD1
H46R, particularly in those
lacking ALS2 (Als2
2/2;SOD1
H46R) (Figure 4, S5B, S5C, S5E, S6A,
and S6B). Further, from 16 weeks of pre- and early-symptomatic
stage, glial intermediate filament proteins, vimentin and glial
fibrillary acidic protein (GFAP), were accumulated (Figure 4, S5J,
S5K, and S6E). Remarkably, the levels of two macroautophagy
(hereafter referred to as autophagy)-associated proteins, polyubi-
quitin binding protein p62/SQSTM1 (p62) and a lipidated-form of
microtubule-associated protein 1-light chain 3 (LC3-II), both of
which were selectively degraded by autophagy-lysosomal system
[36], were significantly increased in insoluble fractions of
Als2
2/2;SOD1
H46R mice (Figure 4, S5G, S5I, S6C, and S6D).
Similar results were obtained in samples from the brainstem,
cerebellum, and cervical cord, but not from the cerebral cortex
(Figure S7). A quantitative reverse transcriptase PCR (qRT-PCR)
revealed that although expression of Vim and Gfap was significantly
upregulated as the disease progressed, no transcriptional activation
of SOD1
H46R, Sqstm1 (p62), and Map1lc3a/Map1lc3b (LC3A/LC3B)
was observed (Figure S4). These results suggest that the accumu-
lation of insoluble mutant SOD1, p62, and LC3-II is not simply due
to an increased expression of these proteins, but rather to a decrease
in their degradation. Since mutant SOD1 is degraded by both the
proteasome and autophagy [37,38], impairment of the ubiquitin-
proteasome system (UPS) and/or the autophagy-endolysosomal
system could result in the accumulation of such insoluble proteins in
SOD1
H46R mice, particularly in those lacking ALS2.
Proteasome activity in the spinal cord is increased as the
disease progresses
To investigate the contribution of UPS impairment on the
protein accumulation observed, we analyzed the catalytic activity
for the 20S proteasome in the spinal cord from mice with different
genotypes. Surprisingly, the proteasomal activity was induced
rather than impaired in SOD1
H46R-expressing mice at a late
symptomatic stage (20 and 23 weeks of age) (Figure 5). Although
loss of ALS2 by itself did not affect the proteasome activity (wild-
type vs Als2
2/2 at 18 weeks of age), ALS2 deficiency in SOD1
H46R
mice seems to result in the earlier enhancement of proteasome
activity in the spinal cord (20 weeks of age) (Figure 5), which might
be correlated with the disease progression. Importantly, the levels
of LMP2, a inducible subunit of immunoproteasome, was
increased in symptomatic Als2
2/2;SOD1
H46R mice (Figure 4),
consistent with recent findings [39,40]. Since the levels of the
constitutive subunits of 20S proteasome (a5 and C2) and one of
the molecular chaperone Hsp70 were unchanged (Figure 4), the
UPS was not severely affected in SOD1
H46R mice, at least, at the
disease stages examined, but rather enhanced in certain cell types
within the spinal cord in response to the disease progression. Thus,
the accelerated accumulation of HMW SOD1 and polyubiquiti-
nated proteins from an early symptomatic stage in SOD1
H46R mice
is not simply due to impairment of the UPS.
SOD1
H46R mice reveal the accumulation of ubiquitin, p62,
and LC3 in the spinal cord
To investigate the cellular localization of the accumulated
insoluble proteins in the spinal cord, we performed immunohis-
Figure 1. Loss of ALS2 results in accelerated body weight loss with shorter lifespan in SOD1
H46R mice. (A) Growth curves for female mice
[wild-type (WT) (black circle; n=14–33), Als2
+/+;SOD1
H46R (blue square; n=6–30), Als2
+/2;SOD1
H46R (green triangle; n=28–84), and Als2
2/2;SOD1
H46R
(red inverted triangle; n=7–44)], and (B) for male mice [WT (n=41–48), Als2
+/+;SOD1
H46R (n=14–46), Als2
+/2;SOD1
H46R (n=9–76), and
Als2
2/2;SOD1
H46R (n=8–36)]. (A–B) In either gender, age at which body weight loss began in Als2
2/2;SOD1
H46R mice was earlier than that for
Als2
+/+;SOD1
H46R mice (female; ***p,0.001, at 22 weeks, male; ***p,0.001 and **p,0.01, at 21 and 22 weeks respectively). There were no differences
in the mean values between Als2
+/+;SOD1
H46R and Als2
+/2;SOD1
H46R mice at any ages. The values for SOD1
H46R-expressing mice (Als2
+/+;SOD1
H46R,
Als2
+/2;SOD1
H46R, and Als2
2/2;SOD1
H46R) later than 8 weeks of ages were all significantly lower than those for WT animals (levels of significance were
not shown). Values are mean6SD. Statistical significance is evaluated by ANOVA with Tukey’s post hoc test. (C) Survival curves for WT [black; n=55
(female; n=14, male; n=41)], Als2
2/2 [orange; n=78 (female; n=32, male; n=46)], Als2
+/+;SOD1
H46R [blue circle; n=48 (female; n=13, male; n=35)],
Als2
+/2;SOD1
H46R [green square; n=132 (female; n=63, male; n=69)], and Als2
2/2;SOD1
H46R [red triangle; n=57 (female; n=27, male; n=30)].
Kaplan-Meier analysis identified significant difference between Als2
2/2;SOD1
H46R and Als2
+/+;SOD1
H46R, and between Als2
2/2;SOD1
H46R and
Als2
+/2;SOD1
H46R (Log-rank test; p,0.0001). (D) Survival curves for Als2
+/+;SOD1
H46R (blue circle; same as C), Als2
+/+;SOD1
H46R;ALS2 [gray square; n=25
(female; n=13, male; n=12)], and Als2
2/2;SOD1
H46R;ALS2 [pink triangle; n=11 (female; n=4, male; n=7)]. Kaplan-Meier analysis identified no
significant differences between groups.
doi:10.1371/journal.pone.0009805.g001
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H46R, a higher
SOD1-immunoreactivity was observed throughout white and gray
matters of the spinal cord (Figure S8A). However, unlike in a case
of SOD1
G93A mice [41], no obvious SOD1-positive inclusions were
detected, at least, in the samples from early symptomatic mice
(Figure S8B), consistent with the notion that SOD1
H46R shows
minimal tendency to form the aggregates or inclusions when
compared with other aggregation-prone SOD1 mutants, such as
SOD1
G93A [42]. HMW insoluble SOD1 observed in immunoblots
(Figure 4) may represent oligomeric forms of SOD1
H46R that are
not analogous to the aggregates of other SOD1 mutants, and are
thus invisible under the light-microscopic observations.
Expression of p62 was evident in microtubule-associated protein
2 (MAP2)-positive large motor neurons but not in GFAP-positive
astrocytes in the spinal cord, and the levels of p62 were higher
in mutant SOD1-expressing mice (Als2
+/+;SOD1
H46R and
Als2
2/2;SOD1
H46R) than in wild-type control (Figure 6A). Further,
compared to Als2
+/+;SOD1
H46R mice, Als2
2/2;SOD1
H46R mice
showed more intense p62-immunoreactivities in both large and
smaller-sized neurons, and the formation of large p62-positive
aggregates was more prominent (Figure 6A). Co-immunostaining
of p62 with a number of cellular markers revealed that although
the p62-positive large aggregates were occasionally colocalized
with MAP2, they were mostly surrounded by astrocytes, but not
colocalized with astrocyte, myelin, oligodendrocyte, or microglia
markers (Figure 6 and data not shown). These results suggest that
the large aggregates are present in extracellular spaces. Impor-
tantly, triple-immunostaning demonstrated that these large
aggregates simultaneously contained p62, ubiquitin, and LC3
(Figure 6B). Thus, it is possible that these ubiquitin/p62/LC3-
positive aggregates in the extracellular space are derived from the
degenerated dendrites and/or axons. Since the accumulated
polyubiquitinated proteins, p62, and LC3-II are a hallmark of
the autophagic defect [36], we hypothesize that loss of ALS2
associates with deregulation of the endolysosomal bulk protein
degradation, thereby aggravating the SOD1
H46R-associated dis-
ease symptoms in mice.
ALS2 is colocalized with autophagosomal proteins in
cultured cells
To investigate the physiological role of ALS2 and its
relationship with the autophagy-associated endolysosomal system,
we performed a colocalization study for ALS2, p62, LC3, and
other organelle markers using cultured cells. Distribution of
ectopically expressed ALS2 and EGFP-LC3 extensively over-
lapped with endogenous p62 in vesicular compartments in
fibroblasts (Figure 7A and 7B). Further, ectopically expressed
ALS2 was colocalized with either endogenous p62 (Figure 7C) or
EGFP-LC3 (Figure 7D) onto the vesicular compartments in
primary hippocampal neurons. Analysis with organella markers in
HeLa cells revealed that ALS2/LC3 double-positive vesicles were
partially co-stained with either p62, early endosome antigen 1
(EEA1; early endosome marker), or lysosome-associated mem-
brane protein 2 (LAMP2; late endosome/lysosome marker)
(Figure S9), but not with the mitochondrial, ER, and Golgi
markers (data not shown). These results indicate that ALS2 is
present not only onto endosomes and macropinosomes [15,16],
but also onto autophagosomes and/or autophagosome/endosome
hybrid vesicular compartments called amphisomes [43].
Figure 2. Loss of ALS2 aggravates motor dysfunction in
SOD1
H46R mice. (A) Changes in the balance beam test scores in
wild-type (WT) (black circle), Als2
2/2 (orange square), Als2
+/+;SOD1
H46R
(blue triangle), Als2
+/2;SOD1
H46R (green inverted triangle), and
Als2
2/2;SOD1
H46R (red diamond) mice. Values are means6SEM [each
genotype; n=20 (female; n=10, male; n=10)]. Statistical significance is
evaluated by ANOVA with Scheffe ´’s post hoc test. There are significant
differences between Als2
+/+;SOD1
H46R (blue) and Als2
2/2;SOD1
H46R (red)
mice (*p,0.05, **p,0.01, or ***p,0.001 at 15–21 weeks of ages), and
between Als2
+/+;SOD1
H46R (blue) and Als2
+/2;SOD1
H46R (green) mice
(++p,0.01 at 21 weeks of age). (B) The rearing and (C) cage activities in
wild-type (Als2
+/+), Als2
+/2;SOD1
H46R, and Als2
2/2;SOD1
H46R mice in a
dark (gray) and a light (white) cycle at 12 and 18 weeks of ages.
Cumulative data counting for 7 consecutive days are shown as Box-
Wisker plots [AU; arbitrary unit, each genotype; n=8–10 (female)].
Statistical significance is evaluated by non-parametric ANOVA (Kruskal-
Wallis) with Dunn’s post hoc test. There are significant differences in the
rearing activities (dark & light) between wild-type (Als2
+/+)a n d
Als2
2/2;SOD1
H46R mice (***p,0.01), in the rearing activities (light)
between Als2
+/2;SOD1
H46R and Als2
2/2;SOD1
H46R mice (***p,0.05), and
in the cage activities between wild-type (Als2
+/+) and Als2
2/2;SOD1
H46R
mice (***p,0.01) at 18 weeks of age.
doi:10.1371/journal.pone.0009805.g002
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H46R-expressing mice show axonal degeneration and swelling in the spinal cord. (A) Representative toluidine blue
staining of the transverse section of lumbar spinal cord (L4–L5) from 18-week-old wild-type (WT; upper row), 16-week-old Als2
+/+;SOD1
H46R (middle
row), and 16-week-old Als2
2/2;SOD1
H46R (lower row) mice. Images for the dorsal columns, lateral columns, ventral columns, and ventral horn cells
were shown. Red arrowheads indicate degenerating axons. Axonal degeneration is most prominent in Als2
2/2;SOD1
H46R mice. Scale bars=20 mm.
(B–F) Representative electron micrographs of lumbar (L4–L5) spinal axons from Als2
2/2;SOD1
H46R mouse at 16 weeks (B–F) and 8 weeks (G).
Degenerating axon (B), axon accumulating fibrillar materials and multivesicular bodies (C and c9), membrane saccule containing granular/osmiophilic
aggregates and autophagosome-like vesicles (D and d9, red arrowhead), axon containing osmiophilic and autophagosome-like (red arrowhead)
vesicles (E and e9), astrocyte containing osmiophilic aggregates (F), and swollen axon accumulating granular aggregates and vesicles (G), are shown.
Scale bars are as indicated.
doi:10.1371/journal.pone.0009805.g003
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clearance of autophagy-associated proteins in fibroblasts
Previously, it has been shown that ALS2 regulates the trafficking
and clearance of internalized molecules such as epidermal growth
factor (EGF) [20] and glutamate receptors [44] in cultured cells. To
further clarify the functional interaction of ALS2 with the
autophagosomal-endolysosomal protein degradation in general,
fibroblasts derived from wild-type and Als2
2/2 mice were subjected
to autophagic-flux analysis [45]. Since the intracellular levels of
LC3-II correlate with the number of autophagosomes, which is
regulated by a balance between autophagosome formation and
degradation, the LC3-II levels in the presence or absence of
lysosomal inhibitors can be used as ‘‘autophagomometer’’ to
measure the autophagic-flux [45]. Under steady-state conditions
(unstarved), the treatment with chloroquine (CQ), a lysosomotropic
agent that inhibits the lysosomal proteases, resulted in a comparable
increase in the LC3-II level in Als2
2/2 cells with those in wild-type
(Figure 8A), indicating that loss of ALS2 by itself does not seem to
Figure 4. ALS2 loss promotes an accumulation of insoluble proteins in the spinal cord of SOD1
H46R mice. Western blot analysis of the
levels of proteins, including ALS2, SOD1, ubiquitin (Ub), polyubiquitin binding protein p62/SQSTM1 (p62), microtubule-associated protein 1-light
chain 3 (LC3), peripherin, neurofilament heavy chain (NFH), TAR DNA-binding protein 43-kD (TDP-43), heat-shock protein Hsp70, 20S proteasome
subunits (a5, C2, and LMP2), vimentin, and glial fibrillary acidic protein (GFAP), in the lumbo-sacral cord from 8, 12, 16, and 20 week-old mice with
four distinct genotypes; wild-type (Als2
+/+), Als2
+/+;SOD1
H46R, Als2
+/2;SOD1
H46R, and Als2
2/2;SOD1
H46R. Two fractions; 1% Triton X-soluble fraction (TX-
soluble; left panels) and 1% Triton X-insoluble/5% SDS-soluble fraction (TX-insoluble; right panels) were analyzed. SOD1_mono and SOD1_HMW
represent monomeric and high molecular-weight (aggregated) forms of SOD1, respectively. Ub_mono and Ub_HMW represent monomeric ubiquitin
and the polyubiquitinated proteins, respectively. LC-I and LC-II are cytosolic and lipidated forms of LC3, respectively. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and b-tubulin served as controls for TX-soluble and TX-insoluble fractions, respectively.
doi:10.1371/journal.pone.0009805.g004
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term starvation in wild-type and Als2
2/2 fibroblasts resulted in
decreased levels of p62 and LC3-II, indicating an enhancement of
autophagy-dependent protein degradation in both cell types
(Figure 8A). Notably, under such starved conditions, the LC3-II
levels in Als2
2/2 cells were significantly higher than those in wild-
type cells (Figure 8A), suggesting that a degree of autophagic
clearance was affected by ALS2 loss.
To confirm this, a quantitative analysis of the LC3-II levels with a
different inhibitor (pepstatin A) was performed. Wild-type fibroblasts
showed a progressive decrease in the levels of LC3-II, which was
partially restored by the pepstatin treatment. By contrast, Als2
2/2
cells exhibited the least effects after a similar starvation, in which the
LC3-II levels in Als2
2/2 cells was significantly higher than those in
wild-type Als2
2/2 cells, and stayed unchanged under the presence of
pepstatin (Figure 8B and 8C), indicating an inefficient lysosomal
clearance of LC3-II in Als2
2/2 cells. Double-immunostaining
experiments also confirmed that loss of ALS2 led to sustained
fluorescent signals of p62 and LC3 after starvation in fibroblasts
(Figure 8D). Importantly, fibroblasts derived from ALS2 overex-
pressing mice (ALS2-tg line L6-2) (Figure S3) showed the opposite
effectsinwhichtheclearanceofLC3-IIwasaccelerated (FigureS10).
We further performed a small interfering RNA (siRNA)-
mediated ALS2 knockdown in HeLa cells, and revealed that the
suppression of ALS2 markedly increased a steady-state level of
LC3-II (Figure S11A and S11B) with accompanying large
perinuclear aggregates and/or vesicles containing LC3 (Figure
S11D). Although the apparent level of p62 was unchanged, p62
was also re-distributed to the perinuclear LC3-positive compart-
ments by suppressing the ALS2 expression (Figure S11C and
S11D). Again, autophagic-flux analysis with the CQ treatment
showed that ALS2 knockdown by itself did not induce autophagy
in HeLa cells (Figure S11C).
Altogether, it is suggested that the accumulation of LC3-II obser-
ved in ALS2 deficient cells is due to a decreased level of clearance,
rather than an increased formation, of autophagosomes and/or
amphisomes. Thus, ALS2 might play an active role in the auto-
phagosomal-endolysosomal trafficking in fibroblasts and HeLa cells.
ALS2 regulates the autophagosomal-endolysosomal
trafficking in cultured spinal motor neurons
To determine whether ALS2 acts as a modulator for the
endolysosomal system in neuronal cells, we investigated the
changes in the level and distribution of p62 and LC3 in
differentiated primary spinal motor neurons after nutrient-
starvation. Since this cell type is very sensitive to lysosomal
inhibitors (data not shown), we avoided the use of such inhibitors
in this experiment. As in fibroblasts, diffused as well as punctated
immunostainings for p62 and LC3 in soma were both decreased
after a transient starvation in the wild-type neuronal cells
(Figure 9A). By contrast, the same treatment induced the
enlargement of LC3/p62-double positive puncta/vesicles in soma
of Als2
2/2 cells (Figure 9A). Quantitative analysis revealed that
the basal level of p62 in Als2
2/2 cells was higher than that of wild-
type cells (Figure 9B and 9C). Further, the levels of p62 in Als2
2/2
cells was unaltered by starvation, while those in wild-type were
significantly decreased (Figure 9C and S12). Collectively, loss of
ALS2 in cultured spinal motor neurons compromises autophago-
somal-endolysosomal trafficking.
SOD1 is partially colocalized with ALS2 and LC3 onto
autophagosome-endosomal compartments in NSC-34
cells
Finally, to investigate the ALS2’s contribution to the degrada-
tion of mutant SOD1, we analyzed the relative changes in the
ectopically-expressed SOD1
H46R levels in cycloheximide-treated
wild-type and Als2
2/2 fibroblasts by the treatment with either the
UPS inhibitor (epoxomicin) or CQ according to the methods as
described [37]. No significant differences in the SOD1
H46R levels
between wild-type and Als2
2/2 cells were detected under the
experimental conditions used (data not shown), indicating that
effects of ALS2 on either the UPS- or lysosome-dependent
SOD1
H46R degradation should be marginal, or undetectable in
short-term cell-culture experiments.
To investigate the relationship between ALS2/LC3-localizing
autophagosome-endosomal compartments and neuronal SOD1
dynamics in more detail, we conducted a series of co-transfection
experiments in the presence of either the UPS or lysosomal
inhibitor using NSC-34 motor neuron-like hybrid cell lines.
Ectopically expressed EGFP-LC3, FLAG-tagged SOD1, and
ALS2 were diffusedly distributed throughout the cytosol with no
colocalization in NSC-34 cells under normal cultured conditions
(Figure 10A). The treatment with the UPS inhibitor (2 mM
MG132, 3hr) induced a formation of small punctated cytoplasmic
aggregates of SOD1 mutants, while the distribution of EGFP-LC3
and ALS2 were unchanged (data not shown). On the other hand,
the CQ treatment resulted in an extensive enlargement of ALS2/
LC3-positve vesicular compartments in NSC-34 cells (Figure 10B).
Intriguingly, ectopically expressed SOD1, namely SOD1
WT and
SOD1
H46R, were frequently colocalized with and accumulated
onto such enlarged vesicular compartments (Figure 10B, white
arrows in enlarged images), supporting the notion that a portion of
cytoplasmic SOD1 is indeed degraded through the autophagy-
endolysosomal system [37,38].
Discussion
ALS2/alsin is an activator for the small GTPase Rab5 [15], and
involves not only in early endosome/macropinosome trafficking
Figure 5. Proteasome activity in the spinal cord of SOD1
H46R
mice is increased as the disease progresses. Chymotrypsin-like
activity in the lumbo-sacral cord from 18, 20, and 23 week-old mice with
four distinct genotypes; wild-type (WT), Als2
2/2, Als2
+/+;SOD1
H46R, and
Als2
2/2;SOD1
H46R are measured. Values are mean 6 SD (n=3–5) in
percent (%) relative to 18 week-old wild-type mice. Statistical
significance is evaluated by ANOVA with Bonferroni’s post hoc test
(*p,0.05, ***p,0.001).
doi:10.1371/journal.pone.0009805.g005
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associated pathological insults, such as toxicity induced by mutant
SOD1 [25,46]. However, molecular mechanisms underlying the
relationship between ALS2-associated cellular function and its
neuroprotective role remain unclear. In this study, we demon-
strated that disturbance of endolysosomal trafficking by ALS2 loss
exacerbated the SOD1
H46R-mediated neurotoxicity by accelerat-
ing the accumulation of immature vesicles and insoluble proteins
in the spinal cord. Thus, ALS2 might play a role in endolysosomal
trafficking in vivo, accounting for the ALS2-assocaited neuropro-
tective function (Figure 11).
It has been reported that overexpression of ALS2 protects
cultured motor neuronal cells from toxicity induced by SOD1
mutants; A4T, G85R, and G93R [25,46]. This protection is
Figure 6. SOD1
H46R-expressing mice show the accumulation of ubiquitin, p62, and LC3 in the spinal cord. (A) Representative images of
triple immunostaining with MAP2 (green), p62 (red), and GFAP (pink) for the ventral horn of the lumbar spinal cord (L4–L5) from 18-week-old wild-
type (WT; 1
st row), 16-week-old Als2
+/+;SOD1
H46R (2
nd row), and 16-week-old Als2
2/2;SOD1
H46R (3
rd row) mice. The nuclei were counterstained with
DAPI (Blue). Scale bars=100 mm. (Lower row) Higher magnification images of p62 immunostaining for the ventral horn of the spinal cord from (a) 18-
week-old WT, (b) 16-week-old Als2
+/+;SOD1
H46R, and (c) 16-week-old Als2
2/2;SOD1
H46R mice. It is notable that loss of ALS2 results in an increased
number of p62-positive smaller-sized neurons (white arrow) and p62-positive extracellular aggregates (white arrowheads). Scale bars=20 mm. (B)
Representative images of triple immunostaining with ubiquitin (Ub) (green), p62 (red), and LC3 (blue) for the ventral horn of the lumbar spinal cord
(L4–L5) from 18-week-old WT (upper row), 16-week-old Als2
+/+;SOD1
H46R (middle row), and 16-week-old Als2
2/2;SOD1
H46R (lower row) mice. Red and
white arrows represent large motor neurons containing cytoplasmic Ub/p62/LC3-positive puncta and extracellular Ub/p62/LC3-positive aggregates,
respectively. The p62-single positive aggregates are also observed (white arrowheads). Scale bars=10 mm.
doi:10.1371/journal.pone.0009805.g006
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ALS2 [25], and such ALS2-mediated neuroprotective function
exerts through the activation of the Rac1/phosphatidylinositol 3-
kinase (PI3K)/Akt prosurvival pathway [46]. However, we were
unable to reconfirm the ALS2 interaction with either wild-type or
SOD1 mutants; H46R, A4V, G93A, and G85R (data not shown),
and the Rac1 activation by ALS2 [16]. In addition, although we
revealed a milder accumulation of wild-type as well as mutant
SOD1 onto ALS2/LC3-double positive autophagosome-endoso-
mal compartments in motor neuron-like cells under dysfunctional
lysosomal conditions, ALS2 per se seems to play a limited role in
the SOD1 degradation in cultured cells (data not shown).
Nonetheless, a significant accumulation of insoluble mutant
SOD1, polyubiquitinated proteins, p62, and LC3-II emerged in
the spinal cord of ALS2 deficient SOD1
H46R mice at an early- or
even pre-symptomatic stage. A large number of studies have
suggested that overexpression of mutant SOD1 results in the
increased levels of misfolded and aggregated proteins [41], which
compromises the UPS for protein degradation [39], and initiates
the ER-associated unfolded protein response (UPR) [47]. Under
such stress conditions, autophagy-lysosomal protein degradation
appears to function as a safeguard for maintaining the cellular
homeostasis [48,49]. Thus, it is possible that the persistent and
long-term excess production of SOD1
H46R, which exceeds the
intracellular capacity for the clearance of misfolded proteins by the
UPS and/or the autophagy-endolysosomal system, results in the
accumulation of insoluble proteins in tissues, and that loss of ALS2
accelerates such phenotypes in vivo.
Intriguingly, we here showed that the proteasome activity was
gradually induced rather than impaired in the spinal cord of
SOD1
H46R-expressing mice as the disease progressed, and that loss
of ALS2 further enhanced their activation. A recent study has
demonstrated that Ub
G76V-GFP reporter-expressing SOD1
G93A
mice show only mild proteasome impairment in motor neurons at
symptomatic stage but not before symptoms onset [39]. These
results suggest that the UPS impairment is not a primary cause for
the accumulation of the insoluble proteins, while the possibility that
the UPS is impaired by perturbing the delivery of ubiquitinated
substrates to the proteasome without affecting the proteasome
activity [50] should not be excluded. On the other hand, both p62
and LC3-II are localized onto autophagosomes and are preferen-
tially degraded by the endolysosomal system [36,50,51]. Thus,
either the excess autophagosome formation or the overwhelmed
endolysosomal system, or both of them, can account for the
observed accumulation of the insoluble proteins such as p62 and
LC3-II in SOD1
H46R-expressing mice. Since ALS2 appears to
regulate endolysosomal protein degradation rather than autopha-
gosome formation, we favor the hypothesis that loss of ALS2
augments the SOD1
H46R-mediated neurotoxicity, albeit its exact
entity is still unclear, by slowing the fusion-mediated endolysosomal
trafficking and/or autophagic clearance of misfolded protein
aggregates (Figure 11). Contrary to our findings, a recent study
has reported the enhanced endolysosomal degradation of glutamate
receptors in Als2
2/2 cells [44]. The reason for this discrepancy is
currently unclear. It may be due to that the fates (degradation and/
or recycling) of membrane bound functional molecules such as
receptors and misfolded/ubiquitinated non-functional protein
aggregates are differently regulated within cells. Indeed, this notion
is supported by the recent findings that loss of histone deacetylase 6
(HDAC6) shows seemingly opposite effects on endolysosome-
dependent protein degradation in cells; HDAC6 loss results in a
failureof autophagosome maturation on the one hand [52], butalso
promotes EGF receptor degradation on the other [53].
Given the role of ALS2 on early endosomal and/or macro-
pinosomal compartments as an activator for Rab5 [15,16], how
does ALS2 regulate rather downstream endolysosomal pathway?
It has been demonstrated that autophagosome maturation is
essential for the degradation of abnormal proteins and organelle
Figure 7. ALS2 is colocalized with LC3 and p62 onto vesicular
compartments in cultured cells. (A) Diffused cytoplasmic distribu-
tion of ectopically expressed ALS2 in wild-type fibroblasts. The cells
were cotransfected with EGFP (green) and ALS2 (blue). Right column
displays the merged image. (B) Punctate distribution of ectopically
expressed ALS2 (blue) colocalizing with EGFP-LC3 (green) and
endogenous p62 (red) in wild-type fibroblasts. The cells were
cotransfected with EGFP-LC3 and ALS2. An ectopic expression of
EGFP-LC3 enhances the vesicular localization of ALS2 in fibroblasts
when compared with EGFP (A). Composite images representing ALS2/
p62-double-positive (a) and LC3/ALS2/p62-triple-positive puncta and/
or vesicles (b, c, and d; white arrowheads) at a higher magnification are
shown. (C) Ectopically expressed ALS2 (green) is colocalized with
endogenous p62 (red) in mice primary hippocampal neurons (white
arrowhead). The cells (DIV11; early stage 5) were transfected with ALS2,
followed by a 12 hr of starvation. (D) Ectopically expressed EGFP-LC3
(green) and ALS2 (red) are colocalized onto perinuclear puncta/vesicles
in mice primary hippocampal neurons (white arrowheads). The cells
(DIV11; early stage 5) were cotransfected with EGFP-LC3 and ALS2,
followed by a 12 hr of starvation. (A–D) Scale bars are as indicated.
doi:10.1371/journal.pone.0009805.g007
ALS2 and Endolysosome Function
PLoS ONE | www.plosone.org 10 March 2010 | Volume 5 | Issue 3 | e9805via the autophagy-lysosome pathway [54]. This maturation is
accomplished by the sequentially fusion of nascent autophago-
somes with late endosomes and lysosomes under the control of
many regulatory factors including endosomal sorting complex
required for transport (ESCRT) and small GTPase Rab7 [54].
Remarkably, it has recently been revealed that the fusion of
autophagosomes with functional early endosomes and endosomal
coatomer is also required for autophagy-dependent protein
degradation [55]. Since ALS2 is colocalized with LC3 and p62
on autophagosome/endosome hybrid membrane compartments
called amphisomes [43], it is conceivable that ALS2 contributes to
the much earlier phase of the autophagosome maturation, i.e.
amphisome formation, via regulating the fusion between early
endosomes and nascent autophagosomes (Figure 11).
An EM analysis revealed an extensive degeneration of spinal
axon with accompanying the accumulation of granular/osmio-
Figure 8. Loss of ALS2 results in decreased levels of the lysosome-dependent degradation of LC3 in fibroblasts. (A) Effect of ALS2
expression on the autophagic flux in fibroblasts. Fibroblasts derived from either wild-type (Als2
+/+)o rAls2
2/2 mice were incubated in a starvation
medium with or without 0.5 mM chloroquine (CQ) for 6 hr. Equal amount of protein from total lysates were analyzed by immunoblotting using
antibodies as indicated. Alpha(a)-tubulin served as control. (B) Effect of ALS2 expression on the autophagic flux in fibroblasts. Fibroblasts derived
from either wild-type (Als2
+/+)o rAls2
2/2 mice were incubated in a starvation medium with or without 20 mg/ml pepstatin A (pepA) for indicated
periods. Equal amount of protein from total lysates were analyzed by immunoblotting using antibodies as indicated. Alpha(a)-tubulin served as
control. (C) Quantitative densitometry for the levels of LC3-II immunoreactive signals shown in B. Data were normalized by the levels of a-tubulin
(LC3-II/a-tubulin). Values are mean6SEM (n=4) in an arbitrary unit relative to control. Statistical significance is evaluated by ANOVA with Bonferroni’s
post hoc test (one-way, compared with respective controls; *p,0.05, ***p,0.001, and two-way, compared between WT and Als2
2/2; +p,0.05). (D)
Representative images for double immunostaining with LC3 (green) and p62 (red) in fibroblasts. Fibroblasts from wild-type (WT) and Als2
2/2 mice
were either left unstarved (0 hr) (upper) or starved for 6 hr (lower). It is notable that a 6 hr of starvation leads to decreased levels of the LC3- and p62-
immunoreactive signals in WT cells, but not in Als2
2/2 cells. Scale bars=50 mm.
doi:10.1371/journal.pone.0009805.g008
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symptomatic SOD1
H46R mice, while spinal motor neurons were
still preserved. This indicates that motor dysfunction seen in these
mice is primarily associated with axonal degeneration rather than
motor neuron loss. Importantly, loss of ALS2 appears to aggravate
such pathological phenotypes in this mice model. In cultured
neurons from wild-type mice, ALS2 is enriched to the membrane
and vesicular compartments at the distal tip [17] as well as at the
branching points (Otomo et al., unpublished) of neurites, and acts
as sustenance in axonal development and function [17].
Interestingly, it has been reported that Rab5 regulates an early
sorting step preceding axonal transport, while Rab7, a regulator
for the endosome/autophagosome-lysosome fusion, regulates
long-rage retrograde axonal transport in motor neurons [56].
Together with our findings, ALS2 may regulate the early step of
endosome and/or autophagosome maturation through the
activation of Rab5 within the axons, and loss of ALS2 results in
an increased number of the immature vesicles, which precludes the
normal long-range axonal vesicle trafficking by Rab7, leading to
the accumulation of MVBs and autophagosome-like vesicles,
axonal swelling, and degeneration in SOD1
H46R mice.
In this study, we demonstrated that loss of ALS2 resulted in a
significant increase in the levels of astrocytic intermediate
filaments, namely those of vimentin from a pre-symptomatic
stage. It has been reported that vimentin is also expressed in motor
neurons, and its expression is upregulated in a number of animal
models for MNDs as the disease progresses [57]. Thus, it is still
possible that neuronal vimentin is responsible for such increments.
However, our preliminary immunohistochemical analysis of
SOD1
H46R and Als2
2/2;SOD1
H46R mice, in which the increased
levels of vimentin were mainly observed in astrocytes rather than
motor neurons in the spinal cord (Otomo et al., unpublished), did
not fit this notion. As there is currently no supportive evidence that
ALS2 is expressed in glial cells including astrocyte [15,19], loss of
ALS2 may lead to insidious adverse effects on neuronal cells,
which in turn initiates and accelerates astrogliosis through some
signaling cross-talk between neurons and astrocytes. Interestingly,
a recent study has shown that ALS2 depleted spinal motor
neurons, but not cortical neurons, are rescued by co-cultured
astrocytes, indicative of a cell-type specific neuron-glia crosstalk
[19]. Further investigation of such neuron-astrocyte interaction on
the pathogenesis is warranted.
Figure 9. Loss of ALS2 lowers the starvation-induced clearance of p62 in cultured motor neurons. (A) Representative confocal images
for double immunostaining with LC3 (green) and p62 (red) in primary spinal motor neurons. The cells (DIV14) from wild-type (WT) and Als2
2/2 mice
were either left unstarved (0 hr) (upper) or starved for 6 hr (lower). A 6 hr of starvation leads to decreased levels of the LC3- and p62-immunoreactive
signals in WT cells. It is notable that a same treatment to Als2
2/2 cells results in the enlargement of LC3/p62-double positive puncta/vesicles in soma.
Scale bars=5 mm. (B) Representative fluorescent microscopic images used for the quantitative analysis of p62-immunostaining in primary spinal
motor neurons shown in C. The cells (DIV14) derived from wild-type (WT) and Als2
2/2 mice were either left unstarved (0 hr) or starved for 6 hr. Scale
bars=10 mm. (C) Quantitation of the p62-immunoreactivity in randomly selected spinal neurons. Signal intensities for the p62-immunoreactivity
relative to unit area of soma (pixel) (AU; arbitrary unit) are shown as Box-Wisker plots [wild-type (WT); 0 hr (n=149) and 6 hr (n=123), Als2
2/2;0h r
(n=127) and 6 hr (n=139)]. Statistical significance is evaluated by non-parametric ANOVA (Kruskal-Wallis) followed by Dunn’s post hoc test. There is a
significant difference in the basal levels of p62 immunoreactive intensities between WT and Als2
2/2 cells (***p,0.001). A 6 hr of starvation results in a
significant decrease in the signal intensities in WT [compared 0 hr (white) with 6 hr (gray), ***p,0.001], but not in Als2
2/2 cells.
doi:10.1371/journal.pone.0009805.g009
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effects of ALS2 loss are specific to H46R mutation in SOD1 or
not. Previously, it has been reported that loss of ALS2 does not
affect the pathological course of SOD1
G93A mice [29,30]. Although
the exact reasons for this discrepancy are unclear, pathological
differences observed between SOD1
H46R and SOD1
G93A mice might
be related. Despite that the expression levels of mutant SOD1;
,20-fold of endogenous SOD1, were comparative between
SOD1
H46R and SOD1
G93A mice (data not shown), the pathology
of the spinal cord was very different. In SOD1
G93A mice, a
prominent distension of mitochondria forming vacuolar structures
with accompanying much faster progression of disease symptoms
was evident [58], while such pathological features were barely
observed in SOD1
H46R mice. Rather, a widespread axonal
degeneration with preserved motor neuron was noticeable in the
spinal cord of SOD1
H46R mice. This suggests that molecular basis
for the pathogenesis in each mutant SOD1-expressing model may
not be the same. Recent findings that dynein mutants crossed with
three different SOD1 mutant animals showed different outcomes
[59] also support this notion. We are currently speculating that
overlapping pathogenic processes between SOD1
H46R and Als2 null
mice; i.e., the axonal degeneration in the spinal cord [6,21,31],
are implicated in the enhancement of the additive adverse
effects. By contrast, a devastating mitochondrial dysfunction in
SOD1
G93A mice overwhelms the modest symptoms by the ALS2
deficiency.
In conclusions, loss of ALS2 impairs the maturation of
autophagosomes, which causes the lowering of the autophagic flux,
thereby accumulating immature vesicles and insoluble misfolded
proteins under stress conditions. Thus, disturbance of the autopha-
gosome-endolysosomal trafficking by ALS2 loss might be a causative
of the manifestations of ALS2-linked MNDs in human. Notably,
functional impairment of other endolysosomal-associated proteins
such as ESCRT subunit and Rab7 also causes motor neuron
dysfunction[60,61].Furthercharacterizationswillgiveusmoreclues
to understanding physiological roles of autophagy-endolysosomal
process in the pathogenesis for ALS and other MNDs.
Materials and Methods
Plasmids
We generated pEGFP-LC3B by subcloning the RT-PCR-
amplified cDNA from mouse brain mRNA. The DNA sequence of
the insert as well as its flanking regions in the plasmid construct
was verified by sequencing. Previously generated ALS2 construct;
pCIneo-hALS2_L [15] was also utilized. Four SOD1 cons-
tructs; pcDNA3-FLAG-SOD1-WT, pcDNA3-FLAG-SOD1-G93A,
pcDNA3-FLAG-SOD1-A4V, pcDNA3-FLAG-SOD1-G85R, were
kindly provided by Dr. Ryosuke Takahashi (Kyoto University). We
additionally generated pcDNA-FLAG-SOD1-H46R by subcloning
the RT-PCR-amplified cDNA fragment from SOD1
H46R mice brain
mRNA.
Figure 10. SOD1 is partially colocalized with ALS2 and LC3 onto autophagosomal/endolysosomal compartments in NSC-34 cells.
(A) Ectopically expressed EGFP-LC3 (LC3), FLAG-tagged SOD1 (SOD1: SOD1
WT; WT, SOD1
H46R; H46R, SOD1
G85R; G85R, SOD1
G93A; G93A, SOD1
A4V; A4V),
and ALS2 were diffusedly distributed throughout the cytosol with no colocalization in NSC-34 cells under normal conditions (Control). (B) Under the
treatment with 50 mM chloroquine for 18 hr, by which endolysosomal protein degradation was severely inhibited, ectopically expressed SOD1
WT,
SOD1
H46R, and SOD1
G85R were partially colocalized with LC3/ALS2 onto enlarged endolysosomal vesicular compartments in NSC-34 cells (white
arrows in enlarged images). Fourth and fifth columns display the merged images for double (LC3 and SOD1) and triple stainings, respectively (A and
B). Sixth columns in B (Enlarge) represent a higher magnification of the merged-images of the respective 5
th columns in B. Scale bars=10 mm.
doi:10.1371/journal.pone.0009805.g010
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then to macropinosomes via macropinocytosis upon Rac1 signaling. Subsequently, ALS2 localizing to nascent macropinosomes activates Rab5 and
enhances the recruitment of EEA1, PI3K/Vps34, and souble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein complex
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Primary antibodies used for western blot analysis included two
independent rabbit polyclonal anti-ALS2; HPF1-680 (1:3,000)
[15] and MPF1012-1651 (1:3,000) [62], rabbit polyclonal anti-
SOD1 (FL-154) (1:20,000, Santa Cruz), mouse monoclonal anti-
ubiquitin (P4D1) (1:3,000, Santa Cruz), guinea pig polyclonal anti-
p62/SQSTM1 (1:6,000, Progen), rabbit polyclonal anti-LC3
(1:5,000, MBL), rabbit polyclonal anti-peripherin (1:5,000,
CHEMICON), mouse monoclonal anti-NFH (1:12,000, Sigma),
rabbit polyclonal anti-TDP-43 (1:2,000, Protein Tech Group),
mouse monoclonal anti-Hsp70 (1:3,000, Santa Cruz), rabbit
polyclonal anti-proteasome 20S subunit alpha-5 (1:3,000, Thermo
Scientific), rabbit polyclonal anti-proteasome 20S C2 (1:3,000,
Thermo Scientific), rabbit polyclonal anti-proteasome 20S LMP2
(Novus), mouse monoclonal anti-vimentin (1:3,000, Sigma), rabbit
polyclonal anti-GFAP (1:50,000, Biomeda), mouse monoclonal
anti-b-tubulin (1:100,000, CHEMICON), mouse monoclonal anti-
a-tubulin (1:10,000, Sigma), and mouse monoclonal anti-glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) (1:10,000, CHE-
MICON) antibodies. Secondary antibodies included horseradish
peroxidase (HRP)-conjugated goat anti-guinea pig IgG (1:5,000,
Santa Cruz), donkey anti-rabbit IgG (1:5,000, Amersham
Bioscience), and sheep anti-mouse IgG (1:5,000, Amersham
Bioscience) antibodies.
Antibodies used for immunohistochemical and immunocyto-
chemical studies included rabbit polyclonal anti-ALS2; HPF1-680
(1:5,000), rabbit polyclonal anti-SOD1 (1:500, MBL), guinea pig
polyclonal anti-p62/SQSTM1 (1:1,000, Progen), rabbit polyclonal
anti-ubiquitin (1:200, DakoCytomation), rabbit polyclonal anti-
LC3 (1:1,000, MBL), rabbit polyclonal anti-MAP2 (1:1,000,
CHEMICON), mouse monoclonal anti-GFAP (1:500, CHEMI-
CON), anti-myelin basic protein (MBP) (1:5,000, GeneTex),
mouse monoclonal anti-EEA1 (1:100, BD biosciences), mouse
monoclonal anti-LAMP2 (1:250, BD biosciences), and mouse
monoclonal anti-FLAG-M2 (1:500, Stratagene) antibodies. Sec-
ondary antibodies included Alexa 594- and Alexa 647-conjugated
goat anti-guinea pig IgG (1:500, Invitrogen), Alexa 488-, Alexa
594-, and Alexa 647-conjugated anti-rabbit IgG (1:500, Invitro-
gen), and Alexa 488-, Alexa 594-, and Alexa 647-conjugated anti-
mouse IgG (1:500, Invitrogen) antibodies.
Animals
We generated SOD1
H46R transgenic mice on an Als2-null
background by crossing Als2
2/2 mice [20] with the SOD1
H46R
mouse line expressing familial ALS-linked SOD1
H46R under the
control of inherent human SOD1 promoter [31]. We first
generated congenic lines of both SOD1
H46R transgenic and
Als2
+/2 mice by each backcrossing more than 10 generations
with C57BL/6N (B6) mice. Next, we produced Als2
+/2;SOD1
H46R
mice by crossing male SOD1
H46R and female Als2
+/2 mice, and
then generated mice with six different genotypes; Als2
+/+ (wild-
type), Als2
+/2, Als2
2/2, Als2
+/+;SOD1
H46R, Als2
+/2;SOD1
H46R,
and Als2
2/2;SOD1
H46R, by crossing male Als2
+/2;SOD1
H46R and
female Als2
+/2 mice. SOD1
G93A mice on a B6 background were
generated by crossing B6SJL-TgN(SOD1-G93A)1Gur males
(Jackson Laboratory) to B6 females for 4–7 generations (N4–N7),
and then SOD1
G93A mice on an Als2-null background were
generated in a similar manner. We further generated transgenic
mice expressing human full-length ALS2 transcript under the
control of the human ALS2 promoter by microinjecting the
construct into fertilized eggs from B6 mice. The construct was
generated by connecting six DNA fragments originated from
human ALS2; two genomic fragments, spanning 22463_
IVS+2307 (4.5 kb; promoter + exon 1 + part of intron 1) and
IVS1-773_IVS1-1 (0.8 kb; part of intron 1), 59 untranslated region
(UTR) of exon 2 (123 bp), the full-length ALS2 cDNA (5 kb; open-
reading frame; ORF), and the 39 UTR (1.3 kb), and a 30 bp of
downstream element (DE) (Figure S3A). All lines of ALS2
transgenic (ALS2-tg) mice were viable and fertile with no evidence
for abnormalities including their lifespan (,2.5 yr). The offsprings
were genotyped by PCR using genomic DNA from tail tissue.
Mice were housed at an ambient temperature of 22uC with a
12 hr light/dark cycle. Food and water were fed ad libitum. Body
weight of each animal was weekly monitored. Their lifespan
(endpoint) was determined by the observations that mice were
unable to move by themselves. All animal experimental proce-
dures were approved by The Institutional Animal Care and Use
Committee at Tokai University.
Behavioral analysis
Motor coordination and balance was assessed by a balance-
beam test using the fixed-stainless steel bar (45 cm long and
0.9 cm in diameter) at 12 weeks of age, and weekly thereafter until
the day at which mice were unable to stay on the bar. Each mouse
was given five trials, and the maximum durations (up to 60 sec) at
which mice fall off from the bar were scored. To evaluate the
spontaneous motor activities in mice, we conducted rearing and
cage activity tests by using SUPERMEX with an infrared ray
sensor monitor (Muromachi Kikai). Both rearing and cage
activities were uninterruptedly monitored for 7 consecutive days
starting at either 12 weeks or 18 weeks of age. The cumulative
counts of rearing and cage activities for either a light- (12 hr; 7:00–
19:00) or a dark-period (12 hr; 19:00–7:00) were analyzed.
Southern blot analysis
The probe DNA spanning the region between introns 3 and 5
for human SOD1 gene (product size; 1,955 bp) was prepared by
PCR amplification using primer sets as follows; hSOD1_probe_L;
59- CCCCTGCTCCCAAATGCTGGAATGC-39, hSOD1_
probe_R; 59- GGGGCCTCAGACTACATCCAAGGG-39. Ge-
nomic DNA samples prepared from tail tissues were digested with
FbaI, separated by electrophoresis, and blotted onto nylon
membrane (Hybond-N+; Amersham Biosciences). The blot was
hybridized with [a
32P-dCTP]-labeled hSOD1_probe, detecting
an ,3.3 kb restriction fragment of the transgene; SOD1
H46R.A s
a control, mouse Actb cDNA encoding b-actin was used as a
probe.
Tissue sample preparation for western blot analysis
Brain and spinal cord tissues were homogenized in Lysis buffer
A [25 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1% (w/v) Triton X-
100 (TX), Complete Protease Inhibitor Cocktail (Roche)], and
(not shown), thereby promoting the maturation (fusion and trafficking) of macropinosomes and early endosomes (EE). In the present study, we show
that ALS2 is also present to the p62/LC3-positive autophagosomes in cells, suggesting that ALS2 plays a role not only in the maturation of
macropinosomes and EE, but also of autophagosomes via their heterotypic fusions, generating amphisomes. The resulting amiphisomes further
mature to late endosomes (LE) accompanying the recruitment of Rab7, and ultimately fuse with lysosomes, thereby cargo molecules including poly-
ubiquitinated proteins are degraded. Poly-ubiquitinated proteins associated with p62 are also degraded by the proteasomes. (B) Loss of ALS2 results
in a decrease in endosome fusion, thereby the maturation of autophagosomes and endolysosomal trafficking are disturbed.
doi:10.1371/journal.pone.0009805.g011
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supernatant was collected as a TX-soluble fraction. The insoluble
pellet fraction was once washed with A buffer, and then suspended
with Lysis buffer B [25 mM Tris-HCl; pH 7.5, 50 mM NaCl, 5%
(w/v) sodium dodecyl sulfate (SDS)], sonicated, and left for 30 min
at room temperature (RT). After the centrifugation at 23,000g for
20 min, the supernatant was collected as a TX-insoulble/SDS-
soluble fraction. Fibroblasts and HeLa cells were harvested and
lysed in Lysis buffer C [50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 0.1% SDS, 1% TX, 0.5% sodium deoxycholate, and
Complete Protease Inhibitor Cocktail (Roche)], and sonicated.
Protein concentration of each fraction was determined by the
Micro BCA system (Pierce).
Western blot analysis
Equal amount of protein (1–2 mg) from each fraction was
subjected to SDS-polyacrylamide gel electrophoresis, and trans-
ferred onto a polyvinylidene difluoride membrane (Bio-Rad). The
membranes were blocked with Blocking One (Nacalai Tesque) for
1 hr at RT, incubated with the primary antibody in TBST
[20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Tween 20]
containing 5% Blocking One (Nacalai Tesque). After washing with
TBST, membranes were incubated with HRP-conjugated second-
ary antibody. Signals were visualized by Immobilon
TM Western
(Millipore) and BioMax X-ray films (Kodak). The bands or signal
intensities were quantified by analyzing the digitally-captured
images using CS Analyzer ver3 (ATTO).
Quantitative reverse transcriptase-PCR (qRT-PCR)
Total RNA was extracted from lumbo-sacral cord using
Sepasol-RNAI (Nakarai Tesque), and purified by SV Total
RNA Isolation System (Promega) according to manufacturer’s
instructions. The qRT-PCR was performed on a 0.5 mg of total
RNA using QuantiFast
TM SYBR Green RT-PCR (Qiagen) with
specific primers (0.6 mM each) as follows; human SOD1; for-
ward (F): 59-AGGGCATCATCAATTTCGAG-39, reverse (R):
59-ACATTGCCCAAGTCTCCAAC-39), Sqstm1 (F: 59-CGGTGA-
AGGCCTATCTTCTG-39,R :5 9-TGTCAGCTCCTCATCAC-
TGG-39), Map1lc3a (F: 59-TGCCTGTCCTGGATAAGACC-39,
R: 59-CCGTCTTCATCCTTCTCCTG-39), Map1lc3b (F:
59-CCGAGAAGACCTTCAAGCAG-39,R :5 9-ACACTTCG-
GAGATGGGAGTG-39), Gfap (F: 59-GCTTCCTGGAACAG-
CAAAAC-39,R :5 9-GCAAAGTTGTCCCTCTCCAC-39), Vim
(F: 59-ACCAGGTCTGTGTCCTCGTC-39,R :5 9-AATAGAG-
GCTGCGGCTAGTG-39), and Gapdh (F: 59-AACTTTGGCAT-
TGTGGAAGG-39,R :5 9-CACATTGGGGGTAGGAACAC-39).
The levels of all transcripts were normalized for the Gapdh mRNA
level in each sample.
20S proteasome activity assay
Spinal cord tissues were homogenized in Lysis buffer D [50 mM
HEPES (pH 7.5), 5 mM EDTA, 150 mM NaCl, 1% (w/v) TX],
and were centrifuged at 23,000g for 20 min at 4uC. Protein
concentration of the resultant supernatant was determined by the
Micro BCA system (Pierce), and adjusted to 2 mg protein/ml with
Lysis buffer D. A 10 ml of each sample (20 mg) was subjected to the
proteasome activity assay using 20S Proteasome Activity Assay Kit
(Chemicon) according to manufacturer’s instructions. The lacta-
cyctin (25 mM)-inhibitable chymotrypsin-like proteasome activity
was measured by quantitating the fluorescent intensity for the
fluorophore 7-amino-4-methylcoumarin (AMC) hydrolyzed from
the substrate peptide; LLVY-AMC using a 360/460 nm filter set
in a fluorometer (CytoFluor 4000; PerSeptive Biosystems).
Histological analysis
Mice were anesthetized with 4% halothane in a mixture of
N2O/O2 (70:30), and transcardially perfused with physiological
saline containing 1,000U/ml heparin, followed by 2% parafor-
maldehyde (PFA)/2% glutaraldehyde (GA) in 0.1 M phosphate
buffer (PB) (pH 7.3). Brain and spinal cord was removed and post-
fixed with the same fixative for 12 hr or 36 hr at 4uC and with 2%
GA for 2 hr at 4uC, followed by washing with 0.1 M PB (pH 7.3).
Lumbar segment was dissected out and post-fixed in 1% osmium
tetroxide in 0.05 M PB (pH 7.4). After dehydration in graded
alcohol, the tissues were embedded in the epoxy resin. Semi-thin
sections (2–3 mm) of L5 lumbar cord were stained with 0.5%
toluidine blue and examined under a computer-assisted light
microscope (BZ-9000, KEYENCE). Selected areas of the spinal
cord were cut into ultrathin sections, and stained with uranyl
acetate and lead citrate for ultrastructural examination using
electron microscopes (H-7100, Hitachi; JEOL1200EX, JEOL).
Immunohistochemical analysis
Anesthetized mice were transcardially perfused with 4% PFA in
0.1 M PB (pH 7.5). Brain and spinal cord were removed and post-
fixed for at least 48 hr in 4% PFA followed by paraffin embedding.
For fluorescent immunohisochemistry, 6 mm paraffin embedded
sections were cut on a microtome, and brain and spinal cord
sections were incubated in phosphate buffered saline (PBS,
pH 7.4) with 5% normal goat serum (NGS) and 0.1% TX for
1 hr at RT. For double- or triple-immunostaining, sections were
incubated with primary antibodies in PBS containing 0.05% TX
overnight at 4uC. Sections were incubated with secondary
antibody for 3 hr at RT. Controls for all immunostainings were
performed simultaneously by omitting the primary antibody.
Sections were coverslipped using VectorShield (Vector Laborato-
ries) with or without 49,6-diamidino-2-phenylindole dihydrochlo-
ride (DAPI) for nuclei counterstaining, and analyzed by a
computer-assisted light microscope (BZ-9000, KEYENCE), or
Leica TCS-NT system (Leica Microsystems) and processed by
ImageJ 1.39u (NIH). All images presented are representative of at
least n=2–3 animals examined in each group at each time point.
Cell culture
HeLa (CCL-2, ATCC) and NSC-34 (CELLutions Biosystems)
cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% heat inactivated fetal bovine
serum (FBS) (Invitrogen), 100 U/ml penicillin G, and 100 mg/ml
streptomycin.
Primary fibroblast cultures were established from E14–E15
mouse embryos. The skin tissues were isolated from pups, washed
with ice-cold Hank’s balanced salt solution devoid of calcium and
magnesium ion [HBSS(-)] (Invitrogen) and treated with 0.5 ml of
0.25% trypsin-EDTA for 15 min at 37uC. Trypsin-EDTA was
removed and washed several times with HBSS(-). Tissue samples
were then treated with DNase I (final 50 mg/ml) in DMEM
supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/
ml streptomycin at RT for 10 min. The dissociated cells were
seeded onto a T75 flask at an appropriate cell density, and
cultured in the same culture medium.
Primary hippocampal neuronal cultures were established from
E18 embryos. In brief, tissues from each embryo were dissected
out and immediately placed into 1 ml of ice-cold HBSS(-). After
removing HBSS(-) by aspiration, 0.5 ml of 0.25% trypsin-EDTA
was added and incubated for 15 min at 37uC. Trypsin-EDTA was
removed and washed several times with 20% FBS/Neurobasal
medium (Invitrogen). Tissue samples were treated with DNase I
(final 50 mg/ml) in 20% FBS/Neurobasal medium for 10 min at
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pellets were dissociated in a 0.6 ml of Neurobasal medium
containing 20% FBS by pipeting using the fire polished Pasteur
pipet. After counting the living cell numbers by the trypan blue
assay, the cells were plated onto poly-D-lysine coated round glasses
at a density of 10
5 cells/mm
2 (days in vivo 1; DIV1) for transfection
in neuronal cell culture (NCC) media [Neurobasal medium
containing 16B27 supplement (Invitrogen), 25 mg/ml insulin
(Sigma), 0.5 mM L-glutamine, 50 mg/ml streptomycin, and
50 U/ml penicillin G], and cultured for 12 hr at 37uC. Medium
was exchanged with the fresh one, and cultured for another 36 hr.
Medium was further replaced with the fresh NCC medium
containing cytosine b-D-arabinofuranoside hydrochloride (Ara-C;
Sigma).
Primary spinal neuronal cultures were established from the
lumbar spinal cord of E14 embryos. In brief, after removal of the
dorsal root ganglia and meninges under microscopic observation,
theventralhornsweredissected using microscalpels,transferredtoa
1.5-ml tube containing 0.5 ml of HBSS(-)/0.025% (w/v) of trypsin,
and incubated for 20 min at 37uC. After the trypsin treatment,
0.5 ml of HBSS(-) was added to the tube. The tissues were
dissociated by gentle pipetting, and then centrifuged at 400g for
10 min at RT. The pellets were suspended in 0.5 ml of HBSS(-).
The resulting suspension was centrifuged through a bovine serum
albumin (BSA) cushion [3% (w/v) in HBSS(-)] at 700g for 10 min at
4uC. The cells obtained at this step represent mixed neuron/glia
population. The cells were resuspended in Neurobasal medium
containing physiological concentrations of Ca
2+ (1.8 mM) and
Mg
2+ (0.8 mM) (Invitrogen) and centrifuged at 1,000g for 10 min at
RT. The pellet was suspended in Neurobasal medium (,400 ml)
containing 16B27, 0.5 mM L-glutamine, 2% FBS, 25 mM2 -
mercaptoethanol, 25 mM glutamate, 50 U/ml penicillin, 50 mg/ml
streptomycin, and 10 ng/ml Brain-derived neurotrophic factor
(BDNF), and seeded onto poly-D-lysine (Sigma) pre-coated glass
cover slips in the wells of a 24-well plate at a density of 5,000 cells/
mm
2. After 24 hr, the medium was replaced with 400 ml of fresh
Neurobasal medium without glutamate, thereafter 100 ml of the
same medium was added three times a week to the cultures for 2
weeks until the fixation.
Transfection
Transfection was performed by using Effectene Transfection
Reagent (Qiagen), Lipofectoamine 2000 (Invitrogen), or Lipofec-
tamine
TM LTX Reagent (Invitrogen) according to the manufac-
turer’s instructions. HeLa and primary neuronal cultures were
transfected with plasmid DNAs as previously described [15,20].
NSC-34 cells were seeded onto a 24 well-plate at a density of
2610
5 cells, cultured for 16 hr, and transfected with an
appropriate amount of plasmid DNAs. After 24 hr of culture,
cells were trypsinized and re-seeded onto a 11 mm round glass
cover slip coated with 0.01% poly-D-lysine and 10 mg/ml laminine
at a density of 5610
4 cells/well. Finally, cells were cultured in
DMEM with 10% FBS for 18 hr in the presence or absence of CQ
(50 mM) or MG132 (10 mM), or a solvent alone (dimethyl
sulfoxide; DMSO) as a control.
Nutrient starvation
Fibroblasts and HeLa cells were seeded onto a 6 well-plate at a
density of 2610
5 cells, and cultured for 24 hr. In case of primary
spinal neurons, dissociated tissues were seeded onto a poly-D-
lysine-coated cover slip and incubated for 14 days (DIV14) under
appropriate conditions (see above). Medium was then exchanged
with Earle’s Balanced Salt Solution (EBSS) (Sigma) lacking FBS,
and cells were cultured for another 6–8 hr either in the presence
or absence of pepstatin A (20 mg/ml) or CQ (0.5 mM or 12.5 mM).
Small Interfering RNA-mediated knockdown of ALS2
To knock down the expression of the endogenous ALS2 gene in
HeLa cells, we conducted the oligonucleotide-based RNA
interference using small interfering RNA (siRNA). In brief,
0.4 ml siRNA (2.5 mM) [ALS2si-1 (SI00128226; QIAGEN),
ALS2si-2 (SI00128219; QIAGEN), ALS2si-3 (SI00128205; QIA-
GEN), ALS2si-4 (SI00128212; QIAGEN), and control (scrambled
siRNA, cat#4611; Ambion)] and 0.8 ml RNAiMAX (Invitrogen)
were mixed with 100 ml OPTI-MEM, and incubated for 20 min at
RT. One-hundred ml of the resulting mixture was transferred onto
a 24 well-plate, and mixed with 400 ml of medium containing
2.5610
4 dissociated HeLa cells with a final siRNA concentration
of 1 nM. After 48 hr of culture, cells were harvested, lysed in Lysis
buffer C, and sonicated. Equal amount of protein from each
sample was subjected to western blot analysis.
Immunocytochemistry
Cells were washed withPBS(-) twice, fixed with 4%PFAin PBS(-)
(pH 7.5) for 20 min, followed by permeabilization with 0.3% TX in
PBS(-) for 20 min or with 100 mg/ml digitonin for 30 min at RT.
The primary antibody, diluted in PBS(-) containing 1.5% normal
goat serum and 50 mg/ml digitonin, was added to cells and
incubated overnight at RT. Appropriate secondary antibodies were
used for the detection of the signals of either the tag epitope or
proteins of interest. Finally, images of optical sections with
0.025 mm thickness were captured and analyzed by Leica TCS_NT
confocal-microscope systems (Leica Microsystems). Randomly
selected images for spinal neurons were digitally-processed by
ImageJ 1.39u (NIH) to demarcate the outline of the cell body, and
fluorescent intensities for p62 signals within the demarcated area
(corresponding to the cell body for the single cell) were measured
using the fluorescence microscopy (Leica) with identical settings.
Statistical analysis
Statistical analyses were conducted using Statview 5 (SAS
Institute) or PRISM 5 (GraphPad). Statistical significance was
evaluated by ANOVA followed by appropriate post hoc tests for
multiple comparisons between groups. Survival data were
compared using Kaplan-Meier survival analysis with Log-rank
(Mantel-Cox) test. A p-value ,0.05 was considered as reaching
statistical significance.
Supporting Information
Figure S1 Copy numbers of the transgene in human
SOD1
H46R transgenic mice on different Als2 genotypes
used were comparable. (Upper panel) Image for the
ethidium bromide-stained mouse genomic DNA digested with
FbaI. Mice with five different genotypes [Als2
+/+;SOD1
H46R (blue),
Als2
+/2;SOD1
H46R (green), Als2
2/2;SOD1
H46R (red), Als2
2/2
(orange), and wild-type (WT) (black), (each n=4)] were analyzed.
Equal amount of genomic DNA (2 mg) was loaded and separated
by agarose gel electrophoresis. The positions of size-markers are
shown on the left. (Middle panel) Southern blot analysis of the
mouse genomic DNA. The FbaI blot was probed with the radio-
labeled human genomic DNA fragment of the SOD1 gene. A
3.3 kbp of the restriction fragment originating from human
SOD1
H46R transgene was specifically detected. (Lower panel)
As a control, the FbaI blot was re-probed with the radio-labeled
mouse Actb (b-actin) cDNA, detecting two fragments originating
from mouse endogenous Actb gene (2.0 and 1.4 kbp).
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Figure S2 Growth curves for Als2
2/2 mice and effect of
ALS2 loss on survival in SOD1
G93A mice. (A) Growth curves
for female mice [wild-type (WT) (black circle; n=16–36) and
Als2
2/2 (orange square; n=32–56)], and (B) for male mice [WT
(n=42–49) and Als2
2/2 (n=46–55)]. (A–B) There were no
differences in the mean values between WT and Als2
2/2 mice at
any ages. Values are mean 6 SD. Statistical significance is
evaluated by ANOVA with Tukey’s post hoc test. (C) Survival
curves for Als2
+/+;SOD1
G93A [blue circle; n=14 (female; n=2,
male; n=12)], Als2
+/2;SOD1
G93A [green square; n=25 (female;
n=13, male; n=12)], and Als2
2/2;SOD1
G93A [red triangle; n=12
(female; n=8, male; n=4)]. Kaplan-Meier analysis identified
significant difference between Als2
+/2;SOD1
G93A and Als2
2/2;
SOD1
G93A (Log-rank test; p=0.0479), while no significance
between Als2
+/+;SOD1
G93A and Als2
2/2;SOD1
G93A was detected.
Found at: doi:10.1371/journal.pone.0009805.s002 (0.36 MB
PDF)
Figure S3 Generation of human full-length ALS2 ex-
pressing mice. (A) Schematic representation of the ALS2
transgenic construct. Human full-length ALS2 transcript is
expressed under the control of the human ALS2 promoter. (B)
Western blot analysis of ALS2 expression in cerebral cortex,
cerebellum, and spinal cord from wild-type (WT) and 4
independent ALS2-tg lines; L6-2, L6-1, L31, and L34-1. Equal
amount of protein from 1% Triton X-soluble fractions (5 I ˆJg) was
loaded in each lane, and anti-ALS2 polyclonal antibody (HPF1-
680) was used to probe ALS2 (180 kDa) as indicated on the right.
Upper and lower panels represent images for short and long
exposures, respectively. The positions of size-markers are shown
on the left.
Found at: doi:10.1371/journal.pone.0009805.s003 (0.29 MB
PDF)
Figure S4 Quantitative analysis of the transcripts in the
spinal cord. The expression levels of (A) the human SOD1
H46R
transgene, (B) Sqstm1 (p62), (C) Map1lc3a (LC3A), (D) Map1lc3b
(LC3B), (E) Gfap, and (F) Vim (vimentin) genes, which are
normalized by the level of Gapdh, in the lumbo-sacral cord from
18, 20, and 23 week-old mice with four distinct genotypes; wild-
type (WT), Als2
2/2, Als2
+/+;SOD1
H46R, and Als2
2/2;SOD1
H46R
are analyzed. Values are mean 6 SEM (n=3–5) in an arbitrary
unit relative to 18 week-old wild-type mice except for the
SOD1
H46R expression in which values relative to 18 week-old
Als2
+/+;SOD1
H46R mice are shown. Statistical significance is
evaluated by ANOVA with Bonferroni’s post hoc test (*p,0.05,
**p,0.01, ***p,0.001).
Found at: doi:10.1371/journal.pone.0009805.s004 (1.07 MB
PDF)
Figure S5 Representative immunoblot-images used in
the quantitative analysis. The immunoblots for (A) soluble
SOD1 monomer, (B) insoluble SOD1 monomer, (C) insoluble
high-molecular weight (HMW) SOD1, (D) soluble polyubiquiti-
nated proteins, (E) insoluble polyubiquitinated proteins, (F) soluble
p62, (G) insoluble p62, (H) LC3-I, (I) LC3-II, (J) insoluble
vimentin, (K) insoluble GFAP (images for CBB-stained gels), (L)
soluble GAPDH, and (M) insoluble b-tubulin were analyzed.
Colored bars drawn above the lanes of each blot indicate the
genotypes of samples [wild-type (WT) (black), Als2
2/2 (orange),
Als2
+/+;SOD1
H46R (blue), Als2
+/2;SOD1
H46R (green), and Als2
2/2;
SOD1
H46R (red)]. C1 (control sample 1) and C2 (control sample 2)
used as internal controls indicate soluble and insoluble fractions
from 23 week-old (end-stage) Als2
+/2;SOD1
H46R mice, respectively.
Immunoreactive bands or area indicated as * on the right are
quantified using CS Analyzer ver3 (ATTO). In this study, in order
to quantify the levels of LC3-II, we used the data obtained form
1% Triton X-100 insoluble fractions (I) rather than soluble ones,
since the majority of the lipidated form of LC3 (LC3-II) was
recovered in this fraction (Figure 4).
Found at: doi:10.1371/journal.pone.0009805.s005 (4.07 MB
PDF)
Figure S6 Quantitative analysis of SOD1, ubiquitin,
p62, LC3, vimentin, and GFAP in the spinal cord. (A)
Quantitation of soluble (1% Triton X-soluble) monomeric SOD1
(SOD1_mono; upper panel), insoluble (1% Triton X-insoluble/
5% SDS-soluble) monomeric SOD1 (SOD_mono; middle panel),
and insoluble high molecular-weight SOD1 (SOD1_HMW; lower
panel). (B) Quantitation of soluble (upper panel) and insoluble
(lower panel) polyubiquitinated proteins (ubiquitin_HMW). (C)
Quantitation of soluble (upper panel) and insoluble (lower panel)
p62. (D) Quantitation of LC3-I (upper panel) and LC3-II (upper
panel). (E) Quantitation of insoluble vimentin (upper panel) and
insoluble GFAP (lower panel). A total of 80 animals [4 animals64
time-points (8, 12, 16, 20 weeks)65 genotypes] were used. The
soluble and insoluble fractions were prepared from the lumbo-
sacral cord of each animal. Densitometric data for immunoreative
signals in soluble and insoluble fractions were normalized by the
levels of GAPDH and b-tubulin, respectively. Values are mean 6
SEM (n=4) in an arbitrary unit relative to 8 week-old wild-type
mice except for the case of SOD1, in which an arbitrary unit
relative to Als2
+/+;SOD1
H46R mice is used. Statistical significance is
evaluated by ANOVA with Bonferroni’s post hoc test. Only the
significant differences between Als2
2/2;SOD1
H46R and the rest of
genotypes are shown (*p,0.05, **p,0.01, ***p,0.001).
Found at: doi:10.1371/journal.pone.0009805.s006 (0.55 MB
PDF)
Figure S7 SOD1
H46R expression causes a progressive
accumulation of insoluble SOD1, ubiquitin, and p62 in
the brainstem, cerebellum, and spinal cord, but not in
the cortex in mice. Western blot analysis of the levels of (A)
SOD1, (B) p62, and (C) ubiquitin in the cortex, brainstem,
cerebellum, cervical cord, and lumbo-sacral cord from 8, 12, 16,
and 20 week-old mice with four distinct genotypes; wild-type
(Als2
+/+), Als2
+/+;SOD1
H46R, Als2
+/2;SOD1
H46R, and Als2
2/2;
SOD1
H46R. Two fractions; 1% Triton X-soluble fraction (TX-
soluble; left panels) and 1% Triton X-insoluble/5% SDS-soluble
fraction (TX-insoluble; right panels) were analyzed. SOD1_mono
and SOD1_HMW represent monomeric and high molecular-
weight (aggregated) forms of SOD1, respectively. Ub_mono and
Ub_HMW represent monomeric ubiquitin and the polyubiquiti-
nated proteins, respectively. The positions of size-markers are
shown on the left (A, C).
Found at: doi:10.1371/journal.pone.0009805.s007 (3.74 MB
PDF)
Figure S8 No obvious SOD1-positive inclusions are
observed in the spinal cord of SOD1
H46R-expressing
early-symptomatic mice. (A) Macro-view for the composite
images for the transverse section of the lumbar spinal cord (L4–L5)
double-immunostained with MAP2 (green) and SOD1 (red) from
16-week-old wild-type (WT; left), 16-week-old Als2
+/+;SOD1
H46R
(middle), and 16-week-old Als2
2/2;SOD1
H46R (right) mice. The
nuclei were counterstained with DAPI (Blue). Scale bar=100 mm.
(B) Representative images of double immunostaining with MAP2
(1st column, green) and SOD1 (2nd column, red) for the ventral
horn of the lumbar spinal cord (L4–L5) from 16-week-old wild-
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+/+;SOD1
H46R (middle
row), and 16-week-old Als2
2/2;SOD1
H46R (lower row) mice. The
nuclei were counterstained with DAPI (3rd column, blue). Scale
bar=100 mm. Scale bar=20 mm.
Found at: doi:10.1371/journal.pone.0009805.s008 (1.03 MB
PDF)
Figure S9 ALS2 is colocalized with autophagosomal and
endosomal proteins onto perinuclear vesicular compart-
ments in HeLa cells. (A) Colocalization of ectopically expressed
ALS2 (green) with endogenous p62 (red; upper), LAMP2 (red;
middle), or EEA1 (red; lower) in HeLa cells. Right columns display
the merged images. (B) Ectopically expressed EGFP-LC3 (green)
and ALS2 (red) are both partially colocalized with either
endogenous p62 (blue; upper row), LAMP2 (blue; middle row),
or EEA1 (blue; lower row) onto perinuclear vesicular compart-
ments in HeLa cells. Third and fifth columns display the merged
images for double (LC3 and ALS2) and triple immunostainings,
respectively. It is notable that ectopic expression of EGFP-LC3
enhances the vesicular localization of ALS2 in HeLa cells. Scale
bars=10 mm.
Found at: doi:10.1371/journal.pone.0009805.s009 (0.46 MB
PDF)
Figure S10 ALS2 enhances the autophagic clearance of
LC3 in fibroblasts. (A) Western blot analysis of the levels of
ALS2, p62, and LC3 in primary fibroblasts from Als2
2/2, wild-
type (WT), and ALS2-tg (line L6-2) mice. Fibroblasts were
incubated in a starvation medium for indicated periods. NT
denotes ‘‘non-treated’’. Equal amount of protein from 1% Triton
X-soluble fractions was loaded in each lane, and analyzed by
immunoblotting using antibodies as indicated. Alpha (a)-tubulin
served as control. Loss of ALS2 lowered the starvation-induced
LC3-II degradation, while ALS2 overexpression led to marked
enhancement of the LC3-II clearance. (B) Colocalization of
ectopically expressed EGFP-LC3 (green) with endogenous p62
(red) in fibroblasts from WT (upper), Als2
2/2 (middle), and ALS2-
tg (lower) mice. Loss of ALS2 resulted in a higher level of EGFP-
LC3-positive puncta/vesicles (green) colocalizing with p62 (mid-
dle). It is notable that EGFP-LC3 (green) was recruited to the
ALS2-induced enlarged vesicles/vacuoles, which might result from
the enhanced endosome fusion by ALS2 overexpression, with a
concomitant decrease in the colocalization with p62 (lower). Right
columns display the merged images. Scale bars=10 mm.
Found at: doi:10.1371/journal.pone.0009805.s010 (0.40 MB
PDF)
Figure S11 ALS2 regulates the level of LC3 in HeLa
cells. (A) Small interfering RNA (siRNA)-mediated suppression of
ALS2 results in an increased level of LC3-II in HeLa cells. The cells
were treated with 3 independent siRNAs for ALS2; ALS2 si-1 (left),
ALS2 si-2 (middle), and ALS2 si-3 (right). Scrambled siRNA was
used as a control. Total lysates were analyzed by immunoblotting
using anti-ALS2 and anti-LC3 antibodies. Alpha-tubulin (a-Tub)
served as control. (B) Quantitative densitometry for the levels of
LC3-II immunoreactive signals shown in A. Data were normalized
by the levels of a-tubulin (LC3-II/a-tubulin). Values are mean 6
SEM (n=4) in an arbitrary unit relative to control. Statistical
significance is evaluated by ANOVA with Bonferroni’s post hoc test
(*p,0.05, ***p,0.001). (C) Effect of siRNA-mediated suppression
of ALS2 on autophagic flux in HeLa cells. The cells were treated
with 4 independent siRNAs for ALS2 (48 hr), followed by the
incubation with or without 12.5 mM chloroquine (CQ) for another
8 hr. Scrambled siRNA was used as a control. Total lysates were
analyzed by immunoblotting using anti-ALS2 and anti-LC3
antibodies. Alpha-tubulin (a-Tub) served as control. (D) Represen-
tative images for double immunostainingswithLC3 (green) and p62
(red) in HeLa cells. The cells were treated with either ALS2-si1 or
control siRNA, followed by a transient starvation (30 min). Right
columns display the merged images. Scale bars=10 mm.
Found at: doi:10.1371/journal.pone.0009805.s011 (1.92 MB
PDF)
Figure S12 Loss of ALS2 results in a decreased level of
starvation-induced autophagic clearance of p62 in
primary spinal neurons. (A–D) Representative p62-immuno-
staining images for primary spinal motor neurons derived from
wild-type (WT) (A and C) and Als2
2/2 (B and D) mice. The cells
(DIV14) were either left unstarved (0 hr) (A and B) or starved for
6h r( C and D). Scale bars=10 I ˆJm. (E and F) Signal intensities
for the p62-immunoreactivity in randomly selected spinal neurons
under unstarved (0 hr; E) and starved (6 hr; F) conditions.
Fluorescent intensities within the digitally-demarcated area
corresponding to the cell body of each cell were measured. Signal
intensity relative to unit area (y-axis) was calculated and expressed
as arbitrary units (AU). The numbers of cells analyzed (x-axis) are
as follows; (E, unstarved) WT; n=149, Als2
2/2; n=127, and (F,
starved) WT; n=123, Als2
2/2; n=139. Blue diamonds and red
squares represent data for WT and Als2
2/2 cells, respectively.
Found at: doi:10.1371/journal.pone.0009805.s012 (2.09 MB
PDF)
Table S1 Genotypes of offsprings produced by crossing
male Als2
+/2;SOD1
H46R and female Als2
+/2mice.
Found at: doi:10.1371/journal.pone.0009805.s013 (0.04 MB
PDF)
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